As market rallied to record highs last quarter, ultra-rich family offices bought beaten up stocks

Hedge-fund and family offices reshuffled portfolios in Q3, buying beaten-up consumer and health names even as AI-fueled gains lifted broader markets, CNBC found in securities filings. David Tepper’s Appaloosa exited its Oracle stake, closed Intel and trimmed Meta positions while dramatically increasing Whirlpool (5.5m shares, a 2,000% increase; $432m, its third-largest holding) and adding to Goodyear, and also raised Nvidia exposure by 9%; Carl Icahn’s office boosted International Flavors & Fragrances by 27% to $292m (with his son joining the IFF board), and Leon Cooperman’s Omega Advisors grew Cigna by 53% (to 325,000 shares) and Elevance by 21% amid both insurers being down ~18% H2. At the same time, Soros Fund Management and Stanley Druckenmiller’s Duquesne bought into mega-cap tech—Soros ramped Apple and Amazon stakes (up 2,000% and 481%, Amazon at $489m) while Duquesne initiated sizable Amazon ($96m) and Meta ($56m) positions—signaling a dual strategy of buying perceived value plays in beaten consumer/health stocks and riding selective Mag-7 momentum.

Analysis

Third-quarter SEC filings show a clear repositioning by ultra-wealthy family offices: Appaloosa exited Oracle and closed its Intel stake while trimming Meta by 8% even as Oracle rallied nearly 29% in the quarter, and simultaneously increased Whirlpool exposure 2,000% to 5.5 million shares (its third-largest holding, worth $432 million) after Whirlpool fell almost 31% in H2. Appaloosa also increased Nvidia exposure by 9%, illustrating profit-taking in some legacy tech names alongside selective doubling down in beaten consumer cyclicals.

Carl Icahn’s office raised International Flavors & Fragrances 27% to $292 million with IFF down 23% YTD and his son joining the IFF board, signaling an activist-driven turnaround bet; Omega Advisors increased Cigna by 53% to 325,000 shares and Elevance by 21% (Elevance quarter-end value $110.2 million) as both insurers trade about 18% lower in H2 amid rising medical costs and anticipated government funding cuts. Soros and Duquesne concurrently ramped or re-entered mega-cap tech—Soros raised Apple and Amazon stakes by 2,000% and 481% (Amazon $489 million quarter-end), and Duquesne initiated Amazon ($96 million) and Meta ($56 million) positions.

These filings point to a bifurcated strategy: buying momentum in AI- and Mag-7-linked tech while selectively investing in beaten consumer and healthcare names where family offices expect mean reversion or activist-driven value creation. The pattern increases idiosyncratic concentration risk and makes near-term performance sensitive to sector-specific catalysts (medical-cost news, activist actions) and the durability of the AI-led market rally.

Key Decisions for Investors

• Consider modest, staged exposure to beaten consumer and insurer names highlighted by family offices (e.g., WHR, IFF, CI, ELV) while sizing positions conservatively given recent large drawdowns and activist/turnaround execution risk
• Trim or hedge positions in recent AI/Mag-7 beneficiaries after strong rallies (Oracle up ~29% this quarter; Appaloosa locked gains) and use option collars or partial profit-taking to manage concentration risk
• Monitor governance and activist developments at IFF and Whirlpool closely as potential catalysts for upside or additional volatility, and watch medical-cost trends and government healthcare funding signals as key risk triggers for insurer holdings
• If adding to beaten names, use dollar-cost averaging and watch family-office disclosure trends as a real-time sentiment signal rather than a sole investment thesis